September 1, 2016 / 4:41 PM / a year ago

BRIEF-Theratechnologies announces commercialization agreement for Tesamorelin in Spain and Portugal

Sept 1 (Reuters) -

* Theratechnologies announces commercialization agreement for Tesamorelin in Spain and Portugal

* Theratechnologies-will manufacture and supply EGRIFTA to Praxis at a predetermined transfer price

* Theratechnologies-concluded agreements With Praxis Pharmaceutical, S.A. and its unit for distribution,commercialization of EGRIFTA in Spain and Portugal

* Theratechnologies-Praxis to conduct regulatory activities necessary for marketing approval for EGRIFTA in Spain ,Portugal

* Theratechnologies-Praxis will distribute EGRIFTA through named patient sales programs Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below